Stress Regulation of Synaptic Transmission
突触传递的压力调节
基本信息
- 批准号:9220469
- 负责人:
- 金额:$ 36.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-04-01 至 2021-03-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAnimalsBehavioralBrainCaenorhabditis elegansCell physiologyCellsCessation of lifeCommunicationDevelopmentDiseaseDisease modelDistalEndocrineGene TargetingGenerationsGeneticGoalsHealthHomologous GeneImpaired cognitionInflammationIntestinesLaboratoriesLeadLinkMammalsModelingMolecularMotorMutationNerve DegenerationNervous system structureNeurodegenerative DisordersNeuromuscular JunctionNeuronsNeuropeptidesNeurosecretory SystemsNeurotransmittersNuclearOrganismOxidative StressParkinson DiseasePathway interactionsPhysiologicalPlayPrincipal InvestigatorProteinsReactive Oxygen SpeciesRegulationResearchResistanceRoleSignal PathwaySignal TransductionSphingolipidsStressStructureSynapsesSynaptic TransmissionTissuesToxic effectbiological adaptation to stressdesignexperimental studyin vivomotor neuron functionneuron lossneuronal survivalneurotransmissionneurotransmitter releasenovel therapeuticspresynapticpreventreceptorresponsesynaptic functiontranscription factor
项目摘要
Principal Investigator: Derek Sieburth
Project Summary
The long-term goal of the proposed research is to identify the mechanisms through which bidirectional
communication between the nervous system and distal tissues regulates organism-wide responses to
oxidative stress. Oxidative stress plays a critical role in cognitive dysfunction and neuronal death
associated with neurodegenerative diseases. Nrf2 is a transcription factor that plays a key role in cellular
resistance to oxidative stress, but little is known about the physiological signals that regulate Nrf2 activity
in the brain or how Nrf2 impacts neuronal function. My laboratory uses the model C. elegans to study new
signaling pathways that modulate presynaptic function. We recently identified the Nrf2 homolog, SKN-1,
as a regulator of presynaptic structure and function. We found that SKN-1/Nrf2 functions cell non-
autonomously to regulate neurotransmitter secretion from neuromuscular junctions. We also found that
neuroendocrine signaling from the nervous system confers organism-wide protection from the toxic effects
of oxidative stress by activating SKN-1/Nrf2 in distal tissues. Here we seek to uncover the cellular and
molecular mechanisms by which bidirectional communication between the nervous system and distal
tissues promotes an adaptive response to oxidative stress through the regulation of neurotransmitter
secretion. In Aim 1, we will determine how SKN-1/Nrf2 activity is positively regulated by neuropeptide
release from the nervous system. In Aim 2, we will determine how reactive oxygen species promote
neuropeptide release in vivo. In Aim 3 we will determine how synaptic transmission is negatively regulated
by cell non-autonomous SKN-1 activation. Nrf2 activation protects neurons form death in a variety of
neurodegenerative disease models, and our research may uncover new endogenous activators of Nrf2,
which may lead to the development of new therapeutics that can prevent or treat these diseases.
主要研究者:Derek Sieburth
项目摘要
拟议研究的长期目标是确定双向
神经系统和远端组织之间的通讯调节生物体范围内的反应,
氧化应激氧化应激在认知功能障碍和神经元死亡中起关键作用
与神经退行性疾病有关。Nrf 2是一种转录因子,在细胞内起关键作用,
抗氧化应激,但对调节Nrf 2活性的生理信号知之甚少
或者Nrf 2如何影响神经元功能。我的实验室用的是C型。elegans研究新
调节突触前功能的信号通路。我们最近发现了Nrf 2的同源物SKN-1,
作为突触前结构和功能的调节器。我们发现,SKN-1/Nrf 2功能细胞非-
自主调节神经肌肉接头的神经递质分泌。我们还发现
来自神经系统的神经内分泌信号赋予生物体范围的保护免受毒性作用
通过激活远端组织中的SKN-1/Nrf 2来抑制氧化应激。在这里,我们试图揭示细胞和
神经系统和远端神经系统之间双向通讯的分子机制
组织通过调节神经递质促进对氧化应激的适应性反应
分泌物在目的1中,我们将确定SKN-1/Nrf 2活性是如何被神经肽正向调节的,
从神经系统中释放出来。在目标2中,我们将确定活性氧如何促进
体内神经肽释放。在目标3中,我们将确定突触传递是如何负调控的
SKN-1细胞非自主激活。Nrf 2激活保护神经元免于死亡,
神经退行性疾病模型,我们的研究可能会发现新的Nrf 2内源性激活剂,
这可能会导致新的治疗方法的发展,可以预防或治疗这些疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DEREK SIEBURTH其他文献
DEREK SIEBURTH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DEREK SIEBURTH', 18)}}的其他基金
Sphingolipid signaling in mitochondrial surveillance
线粒体监测中的鞘脂信号传导
- 批准号:
10468858 - 财政年份:2019
- 资助金额:
$ 36.09万 - 项目类别:
Sphingolipid signaling in mitochondrial surveillance
线粒体监测中的鞘脂信号传导
- 批准号:
10017351 - 财政年份:2019
- 资助金额:
$ 36.09万 - 项目类别:
Sphingolipid signaling in mitochondrial surveillance
线粒体监测中的鞘脂信号传导
- 批准号:
10240608 - 财政年份:2019
- 资助金额:
$ 36.09万 - 项目类别:
Sphingolipid signaling in mitochondrial surveillance
线粒体监测中的鞘脂信号传导
- 批准号:
10683149 - 财政年份:2019
- 资助金额:
$ 36.09万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 36.09万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 36.09万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 36.09万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 36.09万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 36.09万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 36.09万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 36.09万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 36.09万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 36.09万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 36.09万 - 项目类别:














{{item.name}}会员




